Columbus Circle Investors’s Tandem Diabetes Care TNDM Stock Holding History

Columbus Circle Investors’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$29.8M	Sell	311,279 -261,272	-46%	-$26.9M	1.31%	22
2020 Q3	$65M	Sell	572,551 -88,317	-13%	-$9.28M	2.83%	2
2020 Q2	$65.4M	Buy	660,868 +74,839	+13%	+$5.97M	2.63%	2
2020 Q1	$37.7M	Sell	586,029 -78,147	-12%	-$5.48M	2.08%	3
2019 Q4	$39.6M	Sell	664,176 -101,976	-13%	-$6.29M	1.7%	11
2019 Q3	$45.2M	Sell	766,152 -33,471	-4%	-$2.14M	1.66%	7
2019 Q2	$51.6M	Sell	799,623 -14,763	-2%	-$953K	1.38%	17
2019 Q1	$51.7M	Sell	814,386 -34,456	-4%	-$1.81M	1.32%	19
2018 Q4	$32.2M	Buy	848,842 +806,335	+1,897%	+$28.5M	0.91%	41
2018 Q3	$1.82M	Buy	+42,507	New	+$1.48M	0.04%	169

Other funds holding TNDM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Columbus Circle Investors's TNDM Position: Q4 2020 in Review

Columbus Circle Investors reduced its Tandem Diabetes Care (TNDM) stake by 46% in Q4 2020, selling an estimated $26.9M and leaving 311,279 shares worth $29.8M. The position accounts for 1.31% of the portfolio, ranked #22.

Columbus Circle Investors first reported a position in TNDM in Q3 2018 and has held it in 10 quarters since. The position peaked at $65.4M in Q2 2020. 309 funds tracked by Wall St. Rank hold TNDM as of Q4 2020.

Columbus Circle Investors held 311,279 shares of Tandem Diabetes Care worth $29.8M as of Q4 2020.
Columbus Circle Investors sold 261,272 Tandem Diabetes Care shares in Q4 2020, an estimated $26.9M.
Tandem Diabetes Care made up 1.31% of Columbus Circle Investors's portfolio in Q4 2020, its #22 holding.
Columbus Circle Investors first reported a position in Tandem Diabetes Care in Q3 2018 and has held it in 10 quarters since.
Columbus Circle Investors's Tandem Diabetes Care position peaked at $65.4M in Q2 2020.
309 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q4 2020.

Based on Columbus Circle Investors's 13F filing for Q4 2020, filed 20 Jan 2021.